Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Stock Forecast

RLMD's stock price has decreased by -88.72% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Relmada Therapeutics stock ranges from a low of $1.00 to a high of $13. The average price target of $4.25 forecasts a 967.03% increase in the stock price over the next year.

Price Target: $4.25 (+967.03%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$4.25	$2.00	$13
Change	+151.07%	+967.03%	+402.13%	+3163.9%

* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

The average analyst rating for Relmada Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Uy Ear Mizuho	Mizuho	Buy → Hold Downgrades $23 → $1	Buy → Hold	Downgrades	$23 → $1	+151.07%	Dec 5, 2024
Marc Goodman Leerink Partners	Leerink Partners	Buy → Hold Downgrades $10 → $1	Buy → Hold	Downgrades	$10 → $1	+151.07%	Dec 4, 2024
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $3.5 → $13	Hold → Strong Buy	Upgrades	$3.5 → $13	+3,163.87%	Sep 17, 2024
Andrea Tan Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $3 → $2	Hold → Strong Sell	Downgrades	$3 → $2	+402.13%	Jun 5, 2024
Vamil Divan Mizuho	Mizuho	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+6,427.74%	Jun 15, 2023

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -1.02

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-3.81	-7.16	-5.30	-3.28	-2.65	-1.02	-1.57	-0.77
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.16	-0.05	-0.16
Avg	-1.02	-1.57	-0.77
Low	-1.70	-3.04	-1.33

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.